ImpriMed Company
ImpriMed is a company that creates individualized drug response prediction technology to help veterinarians fight lymphoma. The company's technology provides precision medicine techniques that allow veterinary oncologists to find appropriate anticancer drugs by developing a patient-derived database for pet cancer treatment that can eventually be translated into human cancer care, allowing doctors to decide on a final treatment regimen based on a data-driven prediction of response success in each individual patient's body.
%20.jpg)
.png)
(INV)%20.jpg)
Technology:
Predictive Toxicology and ADMET Modeling
Industry:
BioPharma AI
Funding Status:
private
Headquarters:
Mountain View,California,United States,North America
Founded Date:
2017-05-04 00:00:00
Employee Number:
11-50